Leveraging Collaborative Relationships To Enhance Technology And Reach Is Playing A Role In Shaping The Biologics Market

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Biologics Market During 2026–2030?

The biologics market has experienced significant expansion in recent years. Its size is expected to increase from $495.56 billion in 2025 to $540.46 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.1%. The historical growth of this market can be attributed to several factors, including the previously limited availability of biologics, a reliance on traditional therapies, the growing prevalence of immune-related disorders, an expanding healthcare infrastructure, and increasing physician awareness leading to more prescriptions.

The biologics market is anticipated to experience rapid expansion over the next few years, projected to reach $827.24 billion by 2030, growing at a compound annual growth rate (CAGR) of 11.2%. This growth during the forecast period is driven by factors such as the development of novel monoclonal antibodies, the increasing use of mRNA and viral vector vaccines, the rising adoption of personalized biologic therapies, expanding government support and funding for biologics, and the integration of digital health and patient monitoring platforms. Key trends expected in this period include the growing adoption of monoclonal antibodies and therapeutic proteins, an increase in vaccine development, including mRNA and viral vector vaccines, the expansion of prescription-based biologics and hospital pharmacy distribution, a greater focus on personalized medicine and targeted biologic therapies, and the integration of biologics with advanced healthcare solutions and patient monitoring.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3606&type=smp

Which Primary Drivers Are Impacting The Biologics Market Growth?

The rising need for individualized medicine is fueling substantial expansion in the worldwide biologics market. This approach, also termed precision medicine, involves customizing healthcare and treatments based on the unique characteristics of every patient. It provides the capacity to adapt biological therapies to a patient’s distinct genetic and clinical makeup, thereby revolutionizing the healthcare sector. As an illustration, in February 2024, the Personalized Medicine Coalition, a US-based hospital and health care organization, reported that the FDA sanctioned 16 novel personalized treatments for patients with rare diseases in 2023, an increase from six in 2022. Consequently, the growing requirement for personalized medicine is propelling the future growth of the biologics market.

Which Segment Categories Are Included In The Biologics Market Segment Analysis?

The biologics market covered in this report is segmented –

1) By Type: Monoclonal Antibodies (MAbS), Therapeutic Proteins, Vaccines

2) By Drug Classification: Branded Drugs, Generic Drugs

3) By Route Of Administration: Oral, Other Route Of Administration

4) By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies Or Drug Stores, Other Distribution Channels

Subsegments:

1) By Monoclonal Antibodies (MAbs): Naked Monoclonal Antibodies, Conjugated Monoclonal Antibodies, Bispecific Monoclonal Antibodies

2) By Therapeutic Proteins: Hormones, Enzymes, Cytokines, Fusion Proteins

3) By Vaccines: Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, mRNA Vaccines, Viral Vector Vaccines

Which Trends Are Guiding The Direction Of The Biologics Market?

Major companies operating in the biologics market are focusing on developing innovative products such as biosimilars to provide cost-effective alternatives to original biologic therapies. Biosimilars are biologic products highly similar to an already approved reference biologic, with no significant differences in safety, efficacy, or quality, helping reduce treatment costs and increase patient access to advanced therapies. For instance, in July 2025, Biocon Biologics, a subsidiary of Biocon Limited, an India-based biopharmaceutical company, launched Nepexto, a biosimilar to Enbrel (etanercept), in Australia. Nepexto is a fusion-protein biologic designed to inhibit tumor necrosis factor-alpha (TNF-a), a key inflammatory mediator in autoimmune conditions. It is composed of recombinant DNA-derived protein that mimics the binding activity of the original etanercept molecule, delivering comparable efficacy and safety while making treatment more accessible. Its unique features include high biosimilarity backed by robust clinical data, regulatory approvals, and an established supply chain via its local partner Generic Health making it a strong option for long-term management of diseases such as rheumatoid arthritis, psoriasis, and ankylosing spondylitis.

Who Are The Active Companies Shaping The Biologics Market?

Major companies operating in the biologics market are Merck & Co. Inc., AbbVie Inc., F. Hoffmann-La Roche AG, Johnson & Johnson, Pfizer Inc., Bristol Myers Squibb Company, Sanofi S.A., GlaxoSmithKline Plc., Eli Lilly and Company, Amgen Inc., Shanghai Fosun Pharmaceuticals, Bayer AG, Novartis AG, BiosanaPharma, WuXi, Teva UK Limited, AstraZeneca, Abbott Laboratories, Vectura Group, Fujifilm, Lonza, Seqens, Piramal Pharma Solutions, Corden Pharma, Procos SpA and BSP Pharmaceuticals., Microgen, Geropharm, Valenta, NovaMedica, SynBi, Rani Therapeutics, Enteris BioPharma, Allena Pharmaceuticals, Biogen Inc., Emisphere Technologies Inc., Apotex, Gilead Sciences

Get The Full Biologics Market Report:

https://www.thebusinessresearchcompany.com/report/biologics-global-market-report

Which Region Is The Largest In The Biologics Market?

North America was the largest region in the biologics market in 2025. Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the biologics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Biologics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/biologics-global-market-report

Browse Through More Reports Similar to the Global Biologics Market 2026, By The Business Research Company

Cancer Biologics Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report

Orthobiologics Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/orthobiologics-devices-and-equipment-global-market-report

Oral Biologics And Biosimilar Drug Market Report 2026

https://www.thebusinessresearchcompany.com/report/oral-biologics-and-biosimilar-drug-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795